Berikutnya

Putar otomatis

Challenges in treating cancers of unknown primary (CUP)

7 Tampilan • 06/16/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Thomas Helleday, MD, PhD, Karolinska Institute, Stockholm, Sweden & University of Sheffield, Sheffield, UK, highlights the issues with treating cancers of unknown primary (CUP), which result in a poor prognosis for patients. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis